This Government Contract opportunity from Department Of Health And Human Services was posted on May 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Sole Source-Olympus BX53F2 and BX43 Microscopic Systems
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of Health and Human Services, through the National Institutes of Health (NIH) Clinical Center's Department of Laboratory Medicine, intends to award a sole source firm-fixed-price purchase order to Evident Scientific MIS, Inc. for the procurement and installation of Olympus BX53F2 and BX43 clinical microscopy systems, along with integrated camera systems, Cellsens software licenses, and necessary accessories. These systems are critical for supporting hematology diagnostic operations within the NIH Clinical Center, enhancing diagnostic accuracy, workflow efficiency, and staff safety. The acquisition includes two BX53F2 dual observation microscopes with DP75 cameras, two Cellsens software licenses, three BX43 microscopes, one DP23 camera with dual observation attachment, and additional software licenses and accessories. This sole source acquisition is justified by Evident Scientific MIS, Inc.'s unique qualifications as an authorized distributor and service provider of Olympus clinical microscopy systems. They have demonstrated expertise in hardware compatibility, software integration, installation, training, warranty, and technical support tailored for high-complexity clinical laboratory environments. The systems will enhance brightfield visualization, enable real-time image sharing, support pathology reporting workflows, and provide backup imaging during scanner downtime. Interested parties may submit capability statements by May 30, 2026, though the government retains discretion over whether to compete this acquisition. The contracting officer for this acquisition is Shasheshe Goolsby from the NIH Office of Acquisition and Logistics Management.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Agency: Department of Health and Human Services (HHS), National Institutes of Health (NIH), Clinical Center, Department of Laboratory Medicine
Notice Type: Special Notice / Notice of Intent to Sole Source
Authority: This acquisition is being conducted under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
Response Due Date: May 30, 2026 at 4:30 PM EST
Description
The National Institutes of Health (NIH), Clinical Center, Department of Laboratory Medicine intends to negotiate and award a sole source firm-fixed-price purchase order to Evident Scientific MIS, Inc., 140 Kendrick Street, Needham, MA 02494, for the procurement and installation of Olympus BX53F2 and BX43 clinical microscopy systems, integrated camera systems, Cellsens software licenses, and associated accessories required to support Hematology diagnostic operations within the NIH Clinical Center.
Requirement Details
- Two (2) BX53F2 Dual Observation Microscopes with DP75 Cameras
- Two (2) Cellsens software licenses
- Three (3) BX43 Microscopes
- One (1) DP23 Camera with dual observation attachment
- Associated Cellsens software licenses and accessories
Background
The Department of Laboratory Medicine serves as the clinical laboratory for the NIH Clinical Center and provides laboratory support for patient care, clinical research protocols, and training in clinical pathology. The upgraded Olympus microscopy systems are required to improve diagnostic accuracy, workflow efficiency, staff safety, and laboratory compliance within the Hematology Service. The BX53F2 microscopes provide enhanced brightfield visualization with LED illumination to support evaluation of clinically significant cellular morphology and chromatin detail during review of peripheral blood smears and bone marrow specimens. Integrated camera systems and Cellsens software will support real-time case sharing, communication with care teams, backup imaging capability during slide scanner downtime, and SoftPath image integration within pathology reports.
Sole Source Justification
Evident Scientific MIS, Inc. is uniquely qualified as an authorized distributor and service provider for Olympus clinical microscopy systems and has demonstrated the capability to provide compatible hardware, software integration, installation, warranty support, training, and ongoing technical support necessary for high-complexity clinical laboratory operations. The proposed contractor possesses specialized expertise in configuring microscopy systems for hematology and pathology applications, including integration with existing Cellsens imaging software and SoftPath reporting workflows.
Submission Information
THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS. However, interested parties may identify their interest and capability to respond to this requirement by submitting capability statements. Capability statements must demonstrate the ability to provide the required Olympus microscopy systems, integrated software compatibility, installation, warranty support, and related technical services. Please include 26-005825 in all email
Responses to this notice shall be submitted electronically via email no later than the response due date listed above. Responses received after the due date may not be considered.
Contracting Office Contact:
Shasheshe Goolsby
Team Leader
Hospital and Laboratory Support Division
Office of Acquisition and Logistics Management
National Institutes of Health
Email: shasheshe.goolsby@nih.gov
Disclaimer
All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. A determination by the Government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the Government.
